Audax Group has recapitalized Chesapeake Research Review (dba Chesapeake IRB), a healthcare sector service provider. Based in Maryland, Chesapeake provides independent institutional review boards to pharmaceutical, biotech and medical device companies, universities, academic medical centers and hospital systems. Its research projects and principal investigators help assure the protection and welfare of human subjects in clinical trials. Madison Capital Funding provided financing to support the transaction.
